Skip to main content
Article
The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.
Journal of Translational Medicine (2013)
  • Paolo A Ascierto, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Mariaelena Capone, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Walter J Urba, Providence Portland Medical Center
  • Carlo B Bifulco, Providence Portland Medical Center
  • Gerardo Botti, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Alessandro Lugli, University of Bern
  • Francesco M Marincola, Qatar Airways
  • Gennaro Ciliberto, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Jérôme Galon, Pierre-and-Marie-Curie University
  • Jérôme Galon, Paris Descartes University
  • Bernard A Fox, Oregon Health & Science University
  • Bernard A Fox, Providence Portland Medical Center
Publication Date
March 3, 2013
DOI
10.1186/1479-5876-11-54
Citation Information
Paolo A Ascierto, Mariaelena Capone, Walter J Urba, Carlo B Bifulco, et al.. "The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment." Journal of Translational Medicine Vol. 11 Iss. 1 (2013) p. 54 - 54
Available at: http://works.bepress.com/carlo-bifulco/128/